Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd (AJANTPHARM)

₹2384.72.12%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 10 analysts

BUY

80.00%

Buy

10.00%

Hold

10.00%

Sell

Based on 10 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹2476.8

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹2,316.2
    ₹2,389.9
  • 52 Week's Low

    52 Week's High

    ₹1,398.9
    ₹2,540
1 Month Return+ 0.25 %
3 Month Return+ 9.44 %
1 Year Return+ 63.87 %
Previous Close₹2,335.10
Open₹2,339.00
Volume79.15K
Upper Circuit-
Lower Circuit-
Market Cap₹29,403.03Cr

Key Statistics

P/E Ratio36.02
PEG Ratio1.9
Market Cap₹29,403.03 Cr
P/B Ratio8.28
EPS35.5533333333333

Mutual Fund Holdings

Funds HoldingsPrev. 6M
Nippon India Small Cap Fund - Direct Plan - Growth PlanNippon India Small Cap Fund - Direct Plan - Growth Plan0.72%
UTI Flexi Cap Fund - Growth Option - DirectUTI Flexi Cap Fund - Growth Option - Direct1.35%
Kotak Small Cap Direct GrowthKotak Small Cap Direct Growth1.35%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan2.96%
HDFC Large and Mid Cap Fund Direct GrowthHDFC Large and Mid Cap Fund Direct Growth0.83%

Company Information

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Share Price: ₹2384.70 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹29,403.03Cr as of today
Revenue: ₹1,054.08Cr as on March 2024 (Q1 24)
Net Profit: ₹202.72Cr as on March 2024 (Q1 24)
Listing date: 05 Jun, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Ajanta Pharma Ltd

  • Ajanta Pharma Stock Likely to Rally in Forthcoming Sessions - 23 Jul, 2024

    Ajanta Pharma's stock has formed a good base at Rs 2,200 and the broader trend is bullish. In the short term, the price can rise to Rs 2,500 with minor corrections. Participants can buy the stock at Rs 2,290 and accumulate if it dips to Rs 2,210. Place stop-loss at Rs 2,150.

  • Ajanta Pharma Insiders Hold 54% Ownership - 13 Jul, 2024

    Insiders hold the largest stake in Ajanta Pharma with a 54% ownership, indicating inherent interests in company expansion. Institutional investors also have a fair amount of stake.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 66.21% to 66.27% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 7.76% to 7.94% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.76% to 14.84% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AJANTPHARM stock has moved up by 2.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 23.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 69.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 210.03 Cr → 202.72 Cr (in ₹), with an average decrease of 3.5% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.11K Cr → 1.08K Cr (in ₹), with an average decrease of 2.6% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.54% to 8.36% in Jun 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹1,054.08Cr
↓4.62%
Net Income
₹202.72Cr
↓3.48%
Net Profit Margin
19.23%
↑1.21%
2024Y/Y Change
Revenue
₹4,208.71Cr
↑12.45%
Net Income
₹816.17Cr
↑38.81%
Net Profit Margin
19.39%
↑23.42%
Value in ₹ crore
2024Y/Y Change
Total Assets
₹4,252.44Cr
↓2.00%
Total Liabilities
₹838.87Cr
↓23.23%
Value in ₹ crore
2024Y/Y Change
Operating Cash Flow
₹735.35Cr
↓0.13%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
66.27%
0.09
Foreign Institutions
8.36%
-2.09
Mutual Funds
14.84%
0.56
Retail Investors
7.94%
2.36
Others
2.58%
-5.29

Key Indicators

Ajanta Pharma Ltd Valuation

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (36.02x)

July 23, 2024

Industry (56.07x)

July 23, 2024

Highest (40.01x)

December 29, 2023

LowHigh

Earnings and Dividends

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 65.82% since last year same period to ₹202.72Cr in the Q4 2023-2024. On a quarterly growth basis, Ajanta Pharma Ltd has generated -3.48% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Ajanta Pharma Ltd Dividends January,2024

    In the quarter ending December 2023, Ajanta Pharma Ltd has declared dividend of ₹26 - translating a dividend yield of 2.18%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Ajanta Pharma Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Ajanta Pharma Ltd shares.

Ajanta Pharma Ltd (AJANTPHARM) share price today is ₹2384.7

Ajanta Pharma Ltd is listed on NSE

Ajanta Pharma Ltd is listed on BSE

  • Today’s highest price of Ajanta Pharma Ltd is ₹2389.9.
  • Today’s lowest price of Ajanta Pharma Ltd is ₹2316.2.

PE Ratio of Ajanta Pharma Ltd is 36.02

PE ratio = Ajanta Pharma Ltd Market price per share / Ajanta Pharma Ltd Earnings per share

Today’s traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 79.15K.

Today’s market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹29403.03Cr.

Ajanta Pharma Ltd(AJANTPHARMPrice
52 Week High
₹2540
52 Week Low
₹1398.9

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2384.7. It is down -6.11% from its 52 Week High price of ₹2540

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2384.7. It is up 70.47% from its 52 Week Low price of ₹1398.9

Ajanta Pharma Ltd(AJANTPHARMReturns
1 Day Returns
49.6%
1 Month Returns
0.25%
3 Month Returns
9.44%
1 Year Returns
63.87%